Genetic analysis by whole exome sequencing (WES) in a patient with retinal disorder: A Case Study

Document Type : Original Article

Authors

1 Deptartment of Biology, Faculty of Science, University of Sistan and Baluchestan, Zahedan, Iran.

2 Department of Eye Surgery, Faculty of Ophthalmology , Zahedan University of Medical School, Zahedan, Iran

3 Professor,Faculty of Science, Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran.

Abstract

Objective: Retinal hemangioblastoma is part of the symptoms of von Hippel-Lindau (VHL) syndrome, which occurs due to mutations in the VHL gene located on chromosome 3. This gene encodes a protein that plays important roles such as regulating the expression of oxygen-related genes, cilia formation, extracellular matrix formation, etc. Mutations in this gene cause hemangioblastomas of the retina, brain, and spinal cord, as well as a wide range of symptoms such as kidney and pancreatic cysts, etc.
Materials and Methods: This is a laboratory and experimental study in which a female patient suddenly developed blindness in her right eye at the age of 23. After ophthalmological examinations by specialists, blood was taken from the patient to find the main cause of the disease and genetic study, and DNA extraction was performed using the saturated salt method. Then, whole exome sequencing (WES) was performed, and finally, to confirm the candidate mutation and the results of WES, Sanger sequencing was performed.
Results: Based on the findings of this study, a mutation occurred in chromosome number 3 and at position Chr3-10191469 A G:NM_000551:exon3: c.464-2A>G of the VHL gene, in which a nucleotide with a guanine base was replaced by an adenine nucleotide. This mutation is pathogenic and its inheritance is autosomal dominant, and the patient's genotype for this gene was heterozygous, which was directly related to his phenotype and led to the development of von Hippel-Lindau syndrome and impaired retinal function in his right eye.

Keywords

Main Subjects

References

Bamps, S., Calenbergh, F. V., Vleeschouwer, S. D., Loon, J. V., Sciot, R., Legius, E., & Goffin, J. (2013). What the neurosurgeon should know about hemangioblastoma, both sporadic and in Von Hippel-Lindau disease: A literature review. Surgical neurology international, 4, 145. https://doi.org/10.4103/2152-7806.121110
Ben-Yosef T. (2022). Inherited Retinal Diseases. International journal of molecular sciences, 23(21), 13467. https://doi.org/10.3390/ijms232113467
Boll F. (1977). On the anatomy and physiology of the retina. Vision research, 17(11-12), 1249–1265. https://doi.org/10.1016/0042-6989(77)90112-2
Chittiboina, P., & Lonser, R. R. (2015). Von Hippel-Lindau disease. Handbook of clinical neurology, 132, 139–156. https://doi.org/10.1016/B978-0-444-62702-5.00010-X
Cideciyan, A. V., & Jacobson, S. G. (2019). Leber Congenital Amaurosis (LCA): Potential for Improvement of Vision. Investigative ophthalmology & visual science, 60(5), 1680–1695. https://doi.org/10.1167/iovs.19-26672
Cornish, E. E., Vaze, A., Jamieson, R. V., & Grigg, J. R. (2021). The electroretinogram in the genomics era: outer retinal disorders. Eye (London, England), 35(9), 2406–2418. https://doi.org/10.1038/s41433-021-01659-y
Gläsker, S., Neumann, H. P. H., Koch, C. A., & Vortmeyer, A. (2018). Von Hippel-Lindau Disease. In K. R. Feingold (Eds.) et. al., Endotext. MDText.com, Inc
Hamel C. P. (2007). Cone rod dystrophies. Orphanet journal of rare diseases, 2, 7. https://doi.org/10.1186/1750-1172-2-7
Hartong, D. T., Berson, E. L., & Dryja, T. P. (2006). Retinitis pigmentosa. Lancet (London, England), 368(9549), 1795–1809. https://doi.org/10.1016/S0140-6736(06)69740-7
Hu, M. L., Edwards, T. L., O'Hare, F., Hickey, D. G., Wang, J. H., Liu, Z., & Ayton, L. N. (2021). Gene therapy for inherited retinal diseases: progress and possibilities. Clinical & experimental optometry, 104(4), 444–454. https://doi.org/10.1080/08164622.2021.1880863
Hudler, P., & Urbancic, M. (2022). The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis. Genes, 13(2), 362. https://doi.org/10.3390/genes13020362
Jelin, A. C., & Vora, N. (2018). Whole Exome Sequencing: Applications in Prenatal Genetics. Obstetrics and gynecology clinics of North America, 45(1), 69–81. https://doi.org/10.1016/j.ogc.2017.10.003
Kaplan H. J. (2007). Anatomy and function of the eye. Chemical immunology and allergy, 92, 4–10. https://doi.org/10.1159/000099236.
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F. M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., & Geil, L. (1993). Identification of the von Hippel-Lindau disease tumor suppressor gene. Science (New York, N.Y.), 260(5112), 1317–1320. https://doi.org/10.1126/science.8493574
Liu, W., Liu, S., Li, P., & Yao, K. (2022). Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies. International journal of molecular sciences, 23(9), 4883. https://doi.org/10.3390/ijms23094883
Louise M Binderup, M., Smerdel, M., Borgwadt, L., Beck Nielsen, S. S., Madsen, M. G., Møller, H. U., Kiilgaard, J. F., Friis-Hansen, L., Harbud, V., Cortnum, S., Owen, H., Gimsing, S., Friis Juhl, H. A., Munthe, S., Geilswijk, M., Rasmussen, Å. K., Møldrup, U., Graumann, O., Donskov, F., Grønbæk, H., … Sunde, L. (2022). von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance. European journal of medical genetics, 65(8), 104538. https://doi.org/10.1016/j.ejmg.2022.104538
Maher, E. R., & Kaelin, W. G., Jr (1997). von Hippel-Lindau disease. Medicine, 76(6), 381–391. https://doi.org/10.1097/00005792-199711000-00001
Ong, T., Pennesi, M. E., Birch, D. G., Lam, B. L., & Tsang, S. H. (2019). Adeno-Associated Viral Gene Therapy for Inherited Retinal Disease. Pharmaceutical research, 36(2), 34. https://doi.org/10.1007/s11095-018-2564-5
Tsang, S. H., & Sharma, T. (2018). Stargardt Disease. Advances in experimental medicine and biology, 1085, 139–151. https://doi.org/10.1007/978-3-319-95046-4_27
Varshney, N., Kebede, A. A., Owusu-Dapaah, H., Lather, J., Kaushik, M., & Bhullar, J. S. (2017). A Review of Von Hippel-Lindau Syndrome. Journal of kidney cancer and VHL, 4(3), 20–29. https://doi.org/10.15586/jkcvhl.2017.88
Wiley, H. E., Krivosic, V., Gaudric, A., Gorin, M. B., Shields, C., Shields, J., Aronow, M. E., & Chew, E. Y. (2019). MANAGEMENT OF RETINAL HEMANGIOBLASTOMA IN VON HIPPEL-LINDAU DISEASE. Retina (Philadelphia, Pa.), 39(12), 2254–2263. https://doi.org/10.1097/IAE.0000000000002572
Journal of Epigenetics
Volume 6, Issue 1
June 2025
Pages 31-38

Files

History

  • Receive Date: 27 April 2025
  • Accept Date: 26 May 2025

Share

How to cite

Statistics